{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:57:55Z","timestamp":1775613475898,"version":"3.50.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Mycosis fungoides bullosa is a rare clinical subtype of mycosis fungoides, with less than 40 cases reported in the literature. We report a case of a 66-year-old female with a history of stage IIB folliculotrophic mycosis fungoides with large cell transformation, currently being treated with romidepsin and gemcitabine, transferred to our institution due to worsening cutaneous involvement. On exam, there were large, erythematous, crusted and eroded plaques of the neck, trunk, and bilateral upper and lower extremities, some with overlying tense bullae. Punch biopsy showed a marked infiltrate of atypical CD3+ lymphocytes with epidermotropism of predominantly CD4+ cells (CD4:CD8 ratio of 8:1), loss of CD5 and CD7, and scattered CD30+ cells. Direct immunofluorescence showed a non-diagnostic staining pattern. Blood cultures were negative. Given the clinical and histopathologic findings, a diagnosis of mycosis fungoides bullosa was made. Mycosis fungoides is the most common type of cutaneous T-cell lymphoma. Mycosis fungoides bullosa, a vesiculobullous presentation of mycosis fungoides, is a rare variant first described by Dr. Moritz Kaposi in 1887. Proposed mechanisms of bullae formation include confluence of Pautrier\u2019s microabscesses or loss of keratinocyte cohesion due to proliferation of atypical lymphocytes. Diagnosis is based on the presence of vesiculobullous lesions among typical lesions of mycosis fungoides, histopathologic features consistent with mycosis fungoides, and negative evaluation for other causes of vesiculobullous lesions such as infection and autoimmune blistering diseases. Recognition is important as mycosis fungoides bullosa carries poor prognosis, with 50% of reported patients expiring within 1 year of bullae appearance.<\/jats:p>","DOI":"10.1097\/dad.0000000000003135","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T18:01:41Z","timestamp":1758650501000},"page":"965-967","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Vesiculobullous Eruption in Patient With Mycosis Fungoides"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2745-4163","authenticated-orcid":false,"given":"Feifan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin H.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Loyola University Medical Center, Maywood, IL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna J.","family":"Lullo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL;"},{"name":"Department of Dermatology, Loyola University Medical Center, Maywood, IL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah B.","family":"Cadden","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Loyola University Medical Center, Maywood, IL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter","family":"Koster","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson","family":"Schaeffer","sequence":"additional","affiliation":[{"name":"Departmet of Physiology, University of Michigan, Ann Arbor, MI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi J.","family":"Speiser","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"R1-20251120","first-page":"597","article-title":"Mycosis fungoides und ihre Beziehung zu anderen \u20acahnlichen Erkrankungsformen","volume":"37","author":"Kaposi","year":"1887","journal-title":"Wien Med Wochenschr"},{"key":"R2-20251120","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1067\/mjd.2001.117521","article-title":"Mycosis fungoides bullosa: report of a case and review of the literature","volume":"45","author":"Bowman","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R3-20251120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1943.01510040003001","article-title":"Mycosis fungoides with bullous lesions","volume":"48","author":"Garb","year":"1943","journal-title":"Arch Dermatol Syphilology"},{"key":"R4-20251120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdcr.2021.10.019","article-title":"Mycosis fungoides bullosa: an unusual presentation of a rare entity","volume":"18","author":"Nofal","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R5-20251120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1752-1947-4-78","article-title":"Mycosis fungoides bullosa: a case report and review of the literature","volume":"4","author":"Kneitz","year":"2010","journal-title":"J Med case Rep"},{"key":"R6-20251120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jdcr.2023.02.026","article-title":"A case of bullous lesions in cutaneous T-cell lymphoma","volume":"35","author":"Xu","year":"2023","journal-title":"JAAD Case Rep"},{"key":"R7-20251120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1345\/aph.10268","article-title":"Linear immunoglobulin A bullous dermatosis induced by gemcitabine","volume":"35","author":"del Pozo","year":"2001","journal-title":"Ann Pharmacother"},{"key":"R8-20251120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00001813-200309000-00012","article-title":"Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine","volume":"14","author":"Sommers","year":"2003","journal-title":"Anti-Cancer Drugs"},{"key":"R9-20251120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2133.2009.09230.x","article-title":"Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases","volume":"161","author":"Jidar","year":"2009","journal-title":"Br J Dermatol"},{"key":"R10-20251120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.rmed.2005.11.027","article-title":"Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma","volume":"100","author":"Imen","year":"2006","journal-title":"Respir Med"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:08:49Z","timestamp":1763654929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003135","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}